Who we are, and why this site exists

Semaglutides.org is an independent, US-focused guide to GLP-1 medications. We are not affiliated with any drug company.

GLP‑1 medications changed the conversation about weight and diabetes faster than reliable information could keep up. Most of what people find when they search is either a drugmaker's page, a telehealth company selling a prescription, or a news story written for investors. We built Semaglutides.org to be the fourth thing: a plain‑English reference that answers the question you actually typed, shows you exactly where the answer came from, and tells you when we last checked.

What we cover

Every FDA‑approved GLP‑1 medication and the ones in development: semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), orforglipron (Foundayo), liraglutide (Saxenda, Victoza and generics), dulaglutide (Trulicity) and the older drugs. We cover how they work, what they cost, how insurance treats them, what the trials found, what the labels warn about, where the lawsuits stand, how compounding and telehealth fit in, and what happened this week.

How we work

Our research process is built on primary sources: FDA labels and approval letters, ClinicalTrials.gov, peer‑reviewed journals, company filings and court dockets. Every article carries the date it was last verified and links to its sources. Prices are re‑checked against the manufacturer's or vendor's own page before we publish them. When two sources disagree, we say so rather than picking one. Read the editorial policy for the details.

What we are not

We are not doctors, and this site is not medical advice. We never tell you whether to take a medication, which one, or at what dose. We describe what labels, guidelines and studies say so that you can have a better conversation with your own healthcare provider.

We are not affiliated with Novo Nordisk, Eli Lilly or any other drugmaker, pharmacy or telehealth company. Some links to telehealth services are affiliate links; the affiliate disclosure explains how that works and why it does not change what we write.

Corrections

If you find an error, tell us. We correct mistakes promptly and note the change on the page.